All In MedTech

FDA Clearance Tracker · P030036-S158

SelectSecure Lead Model 3830

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 28, 2026 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

May 28, 2026

Approved

Time to decision

90 days

Received Feb 27, 2026. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P030036-S158
Device name
SelectSecure Lead Model 3830
Applicant location
Mounds View, MN
Received
Feb 27, 2026
Decided
May 28, 2026
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P030036

Device type

Device class
Class III

Every decision under product code NVN

FDA's approval statement

As written in FDA's record.

approval for the addition of an alternate supplier of polyurethane resin for use in tissue-contacting components in the SelectSecure Model 3830 Lead family

Source documents

Other decisions for Medtronic Cardiac Rhythm Disease Management

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.